Therapeutics Pitch Deck: ViroMissile

ViroMissile is developing the next generation of oncolytic viruses for cancer diagnosis and treatment. They have created the first-ever stealth oncolytic virus that survives well in blood and is resistant to being cleared by NK and T-cells.

I had the privilege of working with ViroMissile to create the cutting-edge cancer tech company's Series A investor deck and website (live at viromissile.com). 

Full preview • Work with me →

*

Like this showcase design? Get the Figma mockup here: full bundle • freebie